Logo

J&J Visions' Acuvue Theravision with Ketotifen Receives MHLW's Approval for Vision Correction and Allergic Eye Itch

Share this

J&J Visions' Acuvue Theravision with Ketotifen Receives MHLW's Approval for Vision Correction and Allergic Eye Itch

Shots:

  • The MHLW has approved Acuvue Theravision with Ketotifen as the first combination contact lens that provides vision correction and an antihistamine drug to relieve symptoms for people experiencing itchy allergy eyes
  • Data demonstrated that 8 out of 10 contact lens wearers feel frustrated when their eye allergies interfere with normal contact lens wear. The products may help patients to wear contact lenses during the allergy season
  • Acuvue Theravision with Ketotifen marks the first regulatory approval by any health authority while the company is working with authorities globally to bring novel technology to lens wearer

 ­ Ref: PRNewswire | Image: Drug Dangers

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions